CDCL is a term used to encompass various methods and approaches to link TCM with TCM classifications or categories, diseases, and the molecular basis of both diseases and Western therapeutic interventions.

The development of various systems-pharmacology tools and databases has made this concept a reality within the past 10 years, with more publications describing the systems approaches currently in use. these connections are important particularly from the standpoint of integrative medicine practice, but also from the standpoint of research and development, so as to create a clearer understanding of the synergistic and/or antagonistic interactions of components of formulations and of potential combined use with Western therapeutic treatments.


  • 1. K. Cheung and D. Johnson, Chemical-Disease Category Linkage (CDCL): Methods linking traditional Chinese Medicine and Western therapeutics, Toxicologist, 2012, 126(1), 518.
  • 2. E. Chan, M. tan, J. Xin, s. sudarsanam and D. Johnson, Interactions between traditional Chinese Medicines and Western therapeutics, Curr Opin Drug Disc Devel, 2010, 13(1), 58-73.
  • 3. B. Foster, J. Arnason and C. Briggs, Natural Health Products and Drug Disposition, Annu. Rev. Pharmacol. Toxicol., 2005, 45, 203-226.
  • 4. S. Bent, Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation,J. Gen. Intern. Med., 2008, 23(6), 854-859.
  • 5. htm.
  • 6. Fulyzaq: overview.process&varApplNo=202292, Veregan: http://www.accessdata.fda. gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021902.
  • 7. U. Neill, From branch to bedside: Youyou Tu is awarded the 2011 Lasker- DeBakey Clinical Medical Research Award for discovering artemisinin as a treatment for malaria,J. Clin. Invest., 2011, 121(10), 3768-3773.
  • 8. D. Normile, Drug Discovery: Nobel for antimalarial drug highlights East-West divide, Science, 2015, 350(6258), 265, DOI: 10.1126/ science.350.6258.265.
  • 9. Traditional Chinese Medicine Database @ Taiwan, http://tCM.cmu.
  • 10. Traditional Chinese Medicine Integrated Database (TCMID), www.megabi-
  • 11. TCMgeneDIT,
  • 12.
  • 13. Dr Duke’s Phytochemical and Ethnobotanical Databases, duke/.
  • 14. Chem TCM,
  • 15. T. Ehrman, D. Barlow and P. Hylands, Phytochemical informatics of traditional Chinese Medicine and therapeutic Relevance, J. Chem. Inf. Model., 2007, 47, 2316-2334.
  • 16. TCMSP,
  • 17. KEGG, Search under Medicinal Herbs.
  • 18. DrugBank,
  • 19. D. Wishart, C. Knox, A. Guo, s. shrivastara, M. Hassanali, p. stothard, Z. Chang and J. Woolsey, DrugBank: a comprehensive resource for in silico drug discovery and exploration, Nucleic Acids Res., 2006, 34, D668-D672, 16381955.
  • 20. SuperTarget,
  • 21. S. Gunther, M. Kuhn, D. Dunkel, M. Campillos, C. Senger, E. Petsalaki, J. Ahmed, E. Urdiales, A. Gewiess, L. Jensen, R. Schneider, R. Skoblo,

R. Russell, P. Bourne, P. Bork and R. Preissner, SuperTarget and Matador: resources for exploring drug-target relationships, Nucleic Acids Res., 2007, 36, D919-D922.

  • 22. TTD, http:/
  • 23. X. Chen, Z. Ji and Y. Chen, TTD: Therapeutic Target Database, Nucleic Acids Res., 2002, 30, 412-415.
  • 24. MATADOR,
  • 25. PDTD,
  • 26. Z. Gao, H. Li, H. Zhang, X. Liu, L. Kang, X. Luo, W. Zhu, K. Chen,

X. Wang and H. Jiang, PDTD: a web-accessible protein database for drug target identification, BMC Bioinf., 2008, 9, 104, DOI: 10.1186/1471-2105-9-104.

  • 27. TRMP,
  • 28. C. Zheng, H. Zhou, B. Xie, L. Han, C. Yap and Y. Chen, TRMP: a database of therapeutically relevant multiple pathways, Bioinformatics, 2004, 20, 2236-2241.
  • 29. STITCH,
  • 30. M. Kuhn, D. Szklarczyk, S. Pletscher-Frankild, T. Blicher, C. von Mering,

L. Jensen and P. Bork, STITCH4: integration of protein-chemical interactions with user data, Nucleic Acids Res., 2014, 42, D401-D407, DOI: 10.1093/nar/gkt1207.

  • 31. HIT: Herbal Ingredients’ Target Database,
  • 32. H. Ye, L. Ye, H. Kang, D. Zhang, L. Tao, X. Liu, R. Zhu, Q. Liu, Y. Chen, X. Li and Z. Cao, HIT: linking herbal active ingredients to targets, Nucleic Acids Res., 2011, 39, D1055-D1059.
  • 33. KEGG: Kyoto Encyclopedia of Genes and Genomes,, KEGG Pathway Database,
  • 34. WHO Monographs on selected medicinal plants: World Health Organization, vol I 1999 (28 monographs), vol II 2003 (30 monographs), vol III 2007 (31 monographs), vol IV 2009 (28 monographs); Medicinal Plants Commonly used in New Independent States 2010 (13 new monographs, 17 from previous volumes).
  • 35. B. Zhang, X. Wang and S. Li, An Integrative Platform of TCM Network Pharmacology and its Application on a Herbal Formula, Qing-Luo-Yin, J. Evidence-Based Complementary Altern. Med., 2013, 2013, 456747, DOI: 10.1155/2013/456747.
  • 36. B. Li, W. Tao, C. Zheng, P. Shar, C. Huang, Y. Fu and Y. Wang, Systems Pharmacology-based approach for dissecting the addition and subtraction theory of traditional Chinese medicine: and example using xiao-chaihu-decoction and da-chaihu-decoction, Comput. Biol. Med., 2014,53, 19-29.
  • 37. S. Wang, Y. Tong, T.-B. Ng, L. Lao, J. Lam, K. Zhang, Z.-J. Zhang and

S. Sze, Network Pharmacological identification of active compounds and potential actions of Erxian decoction in alleviating menopause-related symptoms, China's Med., 2015, 10, 19, DOI: 10.1186/s13020-015-0051-2.

  • 38. J. Zhao, P. Jiang and W. Zhang, Molecular networks for the study of TCM pharmacology, Briefings Bioinf., 2010, 11(4), 417-430.
  • 39. T. Ehrman, D. Barlow and P. Hylands, In silico search for multi-target anti-inflammatories in Chinese herbs and medicines, Bioorg. Med. Chem., 2010,18, 2204-2218.
  • 40. F. Ding, Q. Zhang, C. Ung, Y. Wang, Y. Han, Y. Hu and J. Qi, An analysis of Cemical Ingredients Network of Chinese Herbal Formulations for the Treatment of Coronary Heart Disease, PLoS One, 2015, 10(2), e0116441, DOI: 10.1371/journal.pone.0116441.
  • 41. M.-Z. Liu, Y.-L. Zhang, M.-Z. Zeng, F.-Z. He, Z.-Y. Luo, J.-Q. Luo, J.-G. Wen, X.-P. Chen, H.-H. Zhou and W. Zhang, Pharmacogenomics and Herb- Drug Interactions. Merge of Future and Tradition, J. Evidence-Based Complementary Altern. Med., 2015, 2015, 456747, DOI: 10.1155/2015/321091.
  • 42. X. Wang, X. Xu, W. Tao, Y. Li, Y. Wang and L. Wang, A systems biology approach to uncovering pharmacological synergy in herbal medicines with applications to cardiovascular diseases, J. Evidence-Based Comple- mentaryAltern. Med., 2012, 2012, 519031, DOI: 10.1155/2012/519031.
  • 43. Comparative Toxicogenomics Database,
  • 44. DAVID 6.7,
  • 45. A. Chu, M. Lin, D. Loomba, J. Ma and D. Johnson, Computational analysis of the combined therapeutic effects of Traditional Chinese Medicines and Western Therapeutics in breast cancer, Toxicologist, 2014, 138(1), 112.
  • 46. Genego Metadrug Thomson Reuters, ucts-services/pharma-life-sciences/pharmaceutical-research/metacore. html.
  • 47. S. Zhao, E. Lin, K. Wei, S. Lu, Y. Chu, Y. Li, Y. Wang, B. Huang, Y. Chen and P. Yang, Interferon plus Chinese herbs are associated with higher sustained virological response than interferon alone in chronic Hepatitis C: A meta-analysis of randomized trials, Antiviral Res., 2011, 89,156-164.
  • 48. H. Kang, K. Tang, Q. Liu, Y. Sun, Q. Huang, R. Zhu, J. Gao, D. Zhang, C. Huang and Z. Cao, HIM-herbal ingredients in-vivo metabolism database, J. Cheminf., 2013, 5, 28,
  • 49. HIM: Herbal Ingredients In vivo Metabolism Database, http://58.40.126. 120:8080/him/.
  • 50. J.-J. Wu, C.-Z. Ai, Y. Liu, Y.-Y. Zhang, M. Jiang, X.-R. Fan, A.-P. Lv and L. Yang, Interactions between phytochemicals from traditional Chinese medicines and human cytochrome p450 enzymes, Curr. Drug Metab., 2012,13,599-614.
  • 51. H.-J. Cho and I.-S. Yoon, Pharmacokinetic interactions of herbs with cytochrome P450 and glycoprotein, J. Evidence-Based Complementary Altern. Med., 2015, 736431, DOI: 10.1155/2015/736431.
  • 52. H.-H. Tsai, H.-W. Liu, Y.-H. Lu, Y.-L. Chen and G. Mahady, A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines, PLoS One, 2013, 8(5), e64255, DOI: 10.1371/journal.pone.0064255.
  • 53. H.-H. Tsai, H.-W. Lin, A. Pickard, H.-Y. Tsai and G. Mahady, Evaluation of Documented Drug Interactions and Contraindications associated with Herbs and Dietary Supplements, Int. J. Clin. Pract., 2012, 66(11), 1056-1078.
  • 54. S. Wanwimolruk and V. Prachayasittikul, Cytochrome P450 enzyme mediated herbal drug interactions (Part1), EXCLI J., 2014, 13, 347-391.
  • 55. S. Wanwimolruk, K. Phopin and V. Prachayasittikul, Cytochrome P450 enzyme mediated herbal drug interactions (Part 2), EXCLI J., 2014, 13, 869-896.
  • 56.
  • 57. herb-drug-interaction-chart.pdf.
  • 58. X. Liu, W.-Y. Wu, B.-H. Jiang, M. Yang and D.-A. Guo, Pharmacological tools for the development of traditional Chinese medicines, Trends Pharmacol. Sci., 2013, 34(11), 620-628.
  • 59. C. Che, Z. Wang, M. Chow and C. Lam, Herb-herb Combination for Therapeutic Enhancement and Advancement: Theory, Practice, and Future Perspectives, Molecules, 2013, 18, 5125-5141.
  • 60. Y. Yao, X. Zhang, Z. Wang, C. Zhen, P. Li, C. Huang, W. Tao, W. Xiao, Y. Wang, L. Huang and L. Yang, Deciphering the combination principles of Traditional Chinese Medicine from a systems pharmacology perspective based on Ma-huang decoction, J. Ethnopharmacol., 2013, 150, 619-638.
  • 61. M. Kibble, N. Saarinen, J. Tang, K. Wennerberg, S. Makela and T. Aittokal- lio, Network pharmacology applications to map unexplored target space and therapeutic potential of natural products, Nat. Prod. Rep., 2015, 32, 1249-1266.
< Prev   CONTENTS   Source   Next >